ConductScience.org, home

Paper458558

Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype.

Lima JJ and 5 others. J Pharmacokinet Biopharm, 1979. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. Papers, record 458558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/458558

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype.
PubMed
Journal
J Pharmacokinet Biopharm
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
2.13
iCite
Revised in PubMed
2026-10-11
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lima JJJ J
2Conti DRD R
3Goldfarb ALA L
4Tilstone WJW J
5Golden LHL H
6Jusko WJW J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProcainamideMajor topic
Acetylation
Adult
Aged
Female
Humans
Kidney Diseases
Kinetics
Male
Middle Aged
Models, Biological
Phenotype
Procaine
Time Factors

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11185521Pharmacokinetics in man of the N-acetylated metabolite of procainamide.J Pharmacokinet Biopharm1975https://conductscience.org/library/papers/1185521PubMed
21153866The pharmacokinetics of procainamide in normal subjects using a specific gas chromatographic assay.Res Commun Chem Pathol Pharmacol1975https://conductscience.org/library/papers/1153866PubMed
3954350Relationship between the pharmacokinetics and pharmacodynamics of procainamide.Clin Pharmacol Ther1976https://conductscience.org/library/papers/954350PubMed
4237647Polymorphic acetylation procainamide in man.Clin Pharmacol Ther1975https://conductscience.org/library/papers/237647PubMed
5902457Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotope methodology.Clin Pharmacol Ther1977https://conductscience.org/library/papers/902457PubMed
61171The renal elimination of procainamide.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1171PubMed
71151617Elimination rate of N-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in man.J Pharmacokinet Biopharm1975https://conductscience.org/library/papers/1151617PubMed
855060Effects of long-term treatment with procaine amide. A prospective study with special regard to ANF and SLE in fast and slow acetylators.Acta Med Scand1975https://conductscience.org/library/papers/55060PubMed
9306574Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.N Engl J Med1978https://conductscience.org/library/papers/306574PubMed
10886461Absorption kinetics of procainamide in humans.J Pharm Sci1977https://conductscience.org/library/papers/886461PubMed
11776488Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions.Clin Pharmacol Ther1976https://conductscience.org/library/papers/776488PubMed
121122681Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotype.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1122681PubMed
131261169Metabolism of procainamide in normal and cardiac subjects.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1261169PubMed
141122675Antiarrhythmic potency of N-acetylprocainamide.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1122675PubMed
15609192Kinetics of procainamide and N-acetylprocainamide in renal failure.Kidney Int1977https://conductscience.org/library/papers/609192PubMed
16322922Dose-ranging trial of N-acetylprocainamide in patients with premature ventricular contractions.Clin Pharmacol Ther1977https://conductscience.org/library/papers/322922PubMed
17618707Determination of procainamide acetylator status.Clin Pharmacol Ther1978https://conductscience.org/library/papers/618707PubMed
1821768Salivary excretion and pharmacokinetics of sulfapyridine after sulfasalazine.Clin Pharmacol Ther1977https://conductscience.org/library/papers/21768PubMed
195055693Pharmacokinetics of procainamide.Arch Intern Med1972https://conductscience.org/library/papers/5055693PubMed
20668789Pharmacokinetic approach to intravenous procainamide therapy.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/668789PubMed

See all 22 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
9084960Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.Clin Pharmacokinet1997https://conductscience.org/library/papers/9084960PubMed
7341758Optimal sampling times for pharmacokinetic experiments.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7341758PubMed
7037261Drug metabolites in renal failure: pharmacokinetic and clinical implications.Clin Pharmacokinet1981https://conductscience.org/library/papers/7037261PubMed
6509861Population pharmacokinetics of procainamide from routine clinical data.Clin Pharmacokinet1984https://conductscience.org/library/papers/6509861PubMed
6178545Clinical pharmacokinetics of N-acetylprocainamide.Clin Pharmacokinet1982https://conductscience.org/library/papers/6178545PubMed
2859977Genetically determined variability in acetylation and oxidation. Therapeutic implications.Drugs1985https://conductscience.org/library/papers/2859977PubMed
2029806Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.Clin Pharmacokinet1991https://conductscience.org/library/papers/2029806PubMed
2014204The role of metabolites in bioequivalency assessment. I. Linear pharmacokinetics without first-pass effect.Pharm Res1991https://conductscience.org/library/papers/2014204PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/458558

GET https://conductscience.org/api/papers/v1/458558/references?page=2